This announcement is a separate document:
京新药业:2024年半年度报告摘要
Zhejiang Jingxin Pharmaceutical: Summary of Half-Year Report in 2024.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Related Stocks Related Stocks
Symbol Mini Chart Latest Price
Unlock the Full List
Latest
13:37
Hisense Group large-scale layoffs? The listed company under its umbrella responded that it has not yet received relevant notifications.
Kantsu+1.79%
13:36
Market update | china tianrui's shares have surged over 1000% after resuming trading, following a 99% plunge in early April this year that led to a suspension.
CHINA TIANRUI+962.50%
13:35
China International Capital Corporation: Shaanxi Coal Industry focuses on both acquisition and dividends, with the potential for the dividend stock attribute to be further highlighted.
Shaanxi Coal Industry-0.32%
Statement
This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.